消息
×
loading..
KMS

浏览/检索结果: 共26条,第1-10条 帮助

  只显示已认领条目
已选(0)清除 条数/页:   排序方式:
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response 期刊论文
EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2025, 卷号: 14, 期号: 1
作者:  Yao, Mingyue;  Yan, Wenzhong;  Wang, Yafang;  Zhao, Yu;  Xu, Xiaowei
Adobe PDF(14589Kb)  |  收藏  |  浏览/下载:85/3  |  提交时间:2025/03/03
新型苯并平类化合物及其组合物和用途 专利
申请号:US18271523,申请日期: 2024-03-07,类型:发明申请,状态:实质审查
发明人:  Dong Guo;  Xudong Cao;  Wenzhong Yan
Adobe PDF(1574Kb)  |  收藏  |  浏览/下载:310/1  |  提交时间:2024/03/08
Design and synthesis of tri-substituted pyrimidine derivatives as bifunctional tumor immunotherapeutic agents targeting both A 2A adenosine receptors and histone deacetylases 期刊论文
CHINESE CHEMICAL LETTERS, 2024, 卷号: 35, 期号: 1
作者:  Liu, Ruiquan;  Duan, Wenwen;  Yan, Wenzhong;  Zhang, Jinfeng;  Cheng, Jianjun
Adobe PDF(961Kb)  |  收藏  |  浏览/下载:396/2  |  提交时间:2023/11/27
三唑酰胺类化合物及其制备方法和用途 专利
申请号:WOCN23084136,申请日期: 2023-10-05,类型:发明申请,状态:未进入国家阶段-PCT有效期满
发明人:  Cheng Jianjun;  Xie Chengying;  Yan Wenzhong;  Yang Kexin
Unknown(7251Kb)  |  收藏  |  浏览/下载:361/0  |  提交时间:2023/10/06
三唑酰胺类化合物及其制备方法和用途 专利
申请号:CN202211494346.2,申请日期: 2023-09-29,类型:发明申请,状态:实质审查
发明人:  程建军;  谢成英;  蒋华良;  闫文仲
Adobe PDF(5474Kb)  |  收藏  |  浏览/下载:454/0  |  提交时间:2023/09/29
Design and Synthesis of Triazole-Containing HDAC Inhibitors That Induce Antitumor Effects and Immune Response 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2023
作者:  Sun, Nan;  Yang, Kexin;  Yan, Wenzhong;  Yao, Mingyue;  Xie, Chengying
Adobe PDF(10205Kb)  |  收藏  |  浏览/下载:419/7  |  提交时间:2023/04/10
Optical-Controlled Kinetic Switch: Fine-Tuning of the Residence Time of an Antagonist Binding to the Vasopressin V2 Receptor in In Vitro, Ex Vivo, and In Vivo Models of ADPKD 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 66, 期号: 2
作者:  Gu, Xiaoke;  Yuan, Haoxing;  Zhao, Wenchao;  Sun, Nan;  Yan, Wenzhong
Adobe PDF(3828Kb)  |  收藏  |  浏览/下载:283/1  |  提交时间:2023/01/16
NOVEL BENZOAZEPINE COMPOUND, AND COMPOSITION AND USE THEREOF 专利
申请号:WOCN21139112,申请日期: 2022-07-28,类型:发明申请,状态:进入国家阶段-PCT有效期满
发明人:  GUO Dong;  CAO Xudong;  YAN Wenzhong;  CHENG Jianjun;  SUN Ying
Unknown(3662Kb)  |  收藏  |  浏览/下载:242/0  |  提交时间:2022/07/29
Long Residence Time at the Vasopressin V-2 Receptor Translates into Superior Inhibitory Effects in Ex Vivo and In Vivo Models of Autosomal Dominant Polycystic Kidney Disease 期刊论文
JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 65, 期号: 11
作者:  Zhang, Haoran;  Yan, Wenzhong;  Sun, Yongzhan;  Yuan, Haoxing;  Su, Limin
Adobe PDF(5188Kb)  |  收藏  |  浏览/下载:267/0  |  提交时间:2022/07/01
Dual-acting antitumor agents targeting the A 2A adenosine receptor and histone deacetylases: Design and synthesis of 4-(furan-2-yl)-1H- pyrazolo[3,4-d]pyrimidin-6-amine derivatives 期刊论文
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2022, 卷号: 5, 期号: 236, 页码: 1-14
作者:  Zhang, Jinfeng;  Luo, Ziwei;  Duan, Wenwen;  Yang, Kexin;  Ling, Lijun
Adobe PDF(2628Kb)  |  收藏  |  浏览/下载:532/2  |  提交时间:2022/06/10
  • 首页
  • 上一页
  • 1
  • 2
  • 3
  • 下一页
  • 末页